3-Eudesmene-1β,11-diol

Catalog No. :
ACJJVP450
CAS No. :
658062-22-7
Molecular Formula :
C15H26O2
Molecular Weight :
238.37

IUPAC Name:(1R,4aS,6R,8aR)-6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-ol

3-Eudesmene-1β,11-diol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$341.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Eudesmene-1β,11-diol
IUPAC Name(1R,4aS,6R,8aR)-6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-ol
MDL No.MFCD28100307
Molecular FormulaC15H26O2
Molecular Weight238.37
SMILESOC(C)(C)[C@H]1C[C@@]2([H])C(C)=CC[C@@H](O)[C@]2(C)CC1
InChI KeyMOURJLAFUXNWJF-QVHKTLOISA-N
Synonym(2R,4aR,5R,8aS)-1,2,3,4,4a,5,6,8a-Octahydro-5-hydroxy-alpha,alpha,4a,8-tetramethyl-2-naphthalenemethanol;3-Eudesmene-1beta,11-diol;2-Naphthalenemethanol, 1,2,3,4,4a,5,6,8a-octahydro-5-hydroxy-α,α,4a,8-tetramethyl-, (2R,4aR,5R,8aS)-;Eudesma-3-en-1β11-diol/3-Eudesmene-1β11-diol;3-Eudesmene-1β,11-diol;2-Naphthalenemethanol,1,2,3,4,4a,5,6,8a-octahydro-5-hydroxy-alpha,alpha,4a,8-tetramethyl-,(2R,4aR,5R,8aS)-;(1S,4aR,6S,8aS)-6-(2-Hydroxypropan-2-yl)-4,8a-dimethyl-2,4a,5,6,7,8-hexahydro-1H-naphthalen-1-ol
CAS No.658062-22-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJJVP450 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJJVP450 route product structure diagram
    ACJJVP450658062-22-7
Inquiry

2. ACJJVP450 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJJVP450 route product structure diagram
    ACJJVP450658062-22-7
Inquiry

Comments (0)